354 related articles for article (PubMed ID: 28546130)
21. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
[TBL] [Abstract][Full Text] [Related]
22. Clusterin expression in medullary thyroid carcinoma is inversely correlated with the presence of lymph node metastases.
Mourra N; Bennis M; Boelle PY; Cochand-Priollet B; Lefevre M; Lepine C; Balaton A; Klijanienko J; Menegaux F; Tissier F
Hum Pathol; 2017 Jun; 64():37-43. PubMed ID: 28411179
[TBL] [Abstract][Full Text] [Related]
23. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
Mendelsohn G; Wells SA; Baylin SB
Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid.
Schmid KW; Kirchmair R; Ladurner D; Fischer-Colbrie R; Böcker W
Histopathology; 1992 Sep; 21(3):225-32. PubMed ID: 1356907
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous occurrence of medullary and papillary carcinoma of the thyroid gland identified by fine needle aspiration. A case report.
Merchant FH; Hirschowitz SL; Cohan P; Van Herle AJ; Natarajan S
Acta Cytol; 2002; 46(4):762-6. PubMed ID: 12146049
[TBL] [Abstract][Full Text] [Related]
26. Undifferentiated (anaplastic) thyroid carcinoma: Practical immunohistochemistry and cytologic look-alikes.
Talbott I; Wakely PE
Semin Diagn Pathol; 2015 Jul; 32(4):305-10. PubMed ID: 25596874
[TBL] [Abstract][Full Text] [Related]
27. Thyroid Tumors You Don't Want to Miss.
Wong KS; Barletta JA
Surg Pathol Clin; 2019 Dec; 12(4):901-919. PubMed ID: 31672297
[TBL] [Abstract][Full Text] [Related]
28. Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Chernock RD; El-Mofty SK; Becker N; Lewis JS
Am J Surg Pathol; 2013 Aug; 37(8):1215-22. PubMed ID: 23681073
[TBL] [Abstract][Full Text] [Related]
29. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck.
Bishop JA; Sharma R; Westra WH
Hum Pathol; 2011 Dec; 42(12):1873-7. PubMed ID: 21663937
[TBL] [Abstract][Full Text] [Related]
30. A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.
Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
[TBL] [Abstract][Full Text] [Related]
31. Histopathological and Immunohistochemical Characteristics of Thyroid Carcinoma in the Dog.
Soares LMC; Pereira AHB; de Campos CG; Rocha LS; Dos Santos TÁ; Souza MA; Jark PC; Pescador CA
J Comp Pathol; 2020 May; 177():34-41. PubMed ID: 32505238
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma.
Kargi A; Yörükoglu ; Aktaş S; Cakalagaoglu ; Ermete M
Thyroid; 1996 Jun; 6(3):207-10. PubMed ID: 8837328
[TBL] [Abstract][Full Text] [Related]
33. Tumor markers and oncogene expression in thyroid cancer using biochemical and immunohistochemical studies.
Hashimoto T; Matsubara F; Mizukami Y; Miyazaki I; Michigishi T; Yanaihara N
Endocrinol Jpn; 1990 Apr; 37(2):247-54. PubMed ID: 1699752
[TBL] [Abstract][Full Text] [Related]
34. Do You Know the Details of Your PAX8 Antibody? Monoclonal PAX8 (MRQ-50) Is Not Expressed in a Series of 45 Medullary Thyroid Carcinomas.
Gucer H; Caliskan S; Kefeli M; Mete O
Endocr Pathol; 2020 Mar; 31(1):33-38. PubMed ID: 31912298
[TBL] [Abstract][Full Text] [Related]
35. Revisiting the Significance of Prominent C Cells in the Thyroid.
Fuchs TL; Bell SE; Chou A; Gill AJ
Endocr Pathol; 2019 Jun; 30(2):113-117. PubMed ID: 30694510
[TBL] [Abstract][Full Text] [Related]
36. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract][Full Text] [Related]
37. Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.
Ragazzi M; Torricelli F; Donati B; Ciarrocchi A; de Biase D; Tallini G; Zanetti E; Bisagni A; Kuhn E; Giordano D; Frasoldati A; Piana S
Virchows Arch; 2021 Feb; 478(2):265-281. PubMed ID: 32683537
[TBL] [Abstract][Full Text] [Related]
38. Possible association of CEA expression with oxyphilic change but not with C-cell hyperplasia in Hashimoto's thyroiditis.
Gakiopoulou H; Litsiou E; Valaris K; Balafoutas D; Patsouris E; Tseleni-Balafouta S
Endocr J; 2010; 57(8):693-9. PubMed ID: 20616436
[TBL] [Abstract][Full Text] [Related]
39. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms.
Tzelepi VN; Tsamandas AC; Vlotinou HD; Vagianos CE; Scopa CD
Mod Pathol; 2008 Jan; 21(1):22-30. PubMed ID: 17962811
[TBL] [Abstract][Full Text] [Related]
40. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
